Zhang, H.;                     Li, Y.;                     Li, J.;                     Li, X.;                     Li, T.    
        Base and Prime Editing for Inherited Retinal Diseases: Delivery Platforms, Safety, Efficacy, and Translational Perspectives. Pharmaceutics 2025, 17, 1405.
    https://doi.org/10.3390/pharmaceutics17111405
    AMA Style
    
                                Zhang H,                                 Li Y,                                 Li J,                                 Li X,                                 Li T.        
                Base and Prime Editing for Inherited Retinal Diseases: Delivery Platforms, Safety, Efficacy, and Translational Perspectives. Pharmaceutics. 2025; 17(11):1405.
        https://doi.org/10.3390/pharmaceutics17111405
    
    Chicago/Turabian Style
    
                                Zhang, Haoliang,                                 Yuxuan Li,                                 Jiajie Li,                                 Xiaosa Li,                                 and Tong Li.        
                2025. "Base and Prime Editing for Inherited Retinal Diseases: Delivery Platforms, Safety, Efficacy, and Translational Perspectives" Pharmaceutics 17, no. 11: 1405.
        https://doi.org/10.3390/pharmaceutics17111405
    
    APA Style
    
                                Zhang, H.,                                 Li, Y.,                                 Li, J.,                                 Li, X.,                                 & Li, T.        
        
        (2025). Base and Prime Editing for Inherited Retinal Diseases: Delivery Platforms, Safety, Efficacy, and Translational Perspectives. Pharmaceutics, 17(11), 1405.
        https://doi.org/10.3390/pharmaceutics17111405